Portal into the Future of Medicines Delivery Technology with Dr. Patrick Anquetil of Portal Instruments

In this episode we hear from Dr. Patrick Anquetil, CEO of Portal
Instruments, a medical device company based in Boston, MA that
aims to make needles and syringes a thing of the past. I asked
Patrick about his journey from graduate research to becoming an
equity analyst, and then returning to Harvard Business School to
pursue his entrepreneurial interests. In his most recent venture,
Portal Instruments, his team has developed a novel drug delivery
technology originally licensed from MIT (lab of Dr. Ian Hunter),
and is commercializing this technology through partnership with
Takeda. We talked about the advantages of this technology over
traditional needles and syringes, and what this means for
patients with various chronic conditions that need to
self-medicate. It was also inspiring to hear him speak about the
importance of creating the right workplace culture to support
integrated teamwork and innovation. He has a unique approach to
leadership, and as I found out, also has a talent for being an
educator. Most importantly, he is a visionary, an innovator, and
he is just starting to tap into the potential of this new
technology. 


If you want to learn more about Portal Instruments you can visits
their website at portalinstruments.com, or contact Patrick at
Patrick.Anquetil@portalinstruments.com.